Towards the development of a targeted albumin-binding radioligand: Synthesis, radiolabelling and preliminary in vivo studies von Driver, Cathryn Helena Stanford, Ebenhan, Thomas, Szucs, Zoltan, Parker, Mohammed Iqbal, Zeevaart, Jan Rijn, Hunter, Roger

Volltext

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial von Maughan, Timothy S, Prof, Adams, Richard A, FRCP, Smith, Christopher G, BSc, Meade, Angela M, DPhil, Seymour, Matthew T, Prof, Wilson, Richard H, MD, Idziaszczyk, Shelley, MPhil, Harris, Rebecca, MSc, Fisher, David, MSc, Kenny, Sarah L, MSc, Kay, Edward, BA, Mitchell, Jenna K, BHSc, Madi, Ayman, MRCP, Jasani, Bharat, Prof, James, Michelle D, BSc, Bridgewater, John, MD, Kennedy, M John, MD, Claes, Bart, MSc, Lambrechts, Diether, PhD, Kaplan, Richard, Prof, Cheadle, Jeremy P, Prof

Volltext

Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 M... von Adams, Richard A, FRCP, Meade, Angela M, DPhil, Seymour, Matthew T, Prof, Wilson, Richard H, MD, Madi, Ayman, MRCP, Fisher, David, MSc, Kenny, Sarah L, MSc, Kay, Edward, BA, Hodgkinson, Elizabeth, BPharm, Pope, Malcolm, Rogers, Penny, BSc, Wasan, Harpreet, FRCP, Falk, Stephen, MD, Gollins, Simon, DPhil, Hickish, Tamas, MD, Bessell, Eric M, PhD, Propper, David, MD, Kennedy, M John, MD, Kaplan, Richard, Prof, Maughan, Timothy S, Prof

Volltext

Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial von Geddes, John R, Goodwin, Guy M, Rendell, Jennifer, Azorin, Jean-Michel, Cipriani, Andrea, Ostacher, Michael J, Morriss, Richard, Alder, Nicola, Juszczak, Ed

Volltext